Secura Bio develops and commercializes targeted biopharmaceutical therapies for patients with serious illnesses, focusing on improving treatment accessibility. The company addresses the challenge of limited treatment options by providing innovative medicines that meet critical patient needs.
Funding
$145M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients facing serious illnesses often have limited treatment options, creating a critical need for innovative medicines that can improve their quality of life and overall outcomes. The accessibility of these therapies can also be a significant barrier, particularly for those in underserved communities or with limited resources.
Solution
Secura Bio focuses on developing and commercializing targeted biopharmaceutical therapies designed to address the unmet needs of patients with serious illnesses. By providing innovative medicines, Secura Bio aims to expand treatment options and improve accessibility for those who need them most. The company is committed to delivering life-changing products that can make a meaningful difference in the lives of patients and their families.
Target Audience
The primary target audience includes patients diagnosed with serious illnesses and the healthcare professionals who treat them.
Features
- Development of targeted biopharmaceutical therapies
- Focus on serious illnesses with unmet medical needs
- Commercialization of innovative medicines
- Commitment to improving treatment accessibility